Literature DB >> 16737901

Characterization of proteome of human cerebrospinal fluid.

Jing Xu1, Jinzhi Chen, Elaine R Peskind, Jinghua Jin, Jimmy Eng, Catherine Pan, Thomas J Montine, David R Goodlett, Jing Zhang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16737901     DOI： 10.1016/S0074-7742(06)73002-1

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN： 0074-7742            Impact factor:   3.230


× No keyword cloud information.
  10 in total

1.  In-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantification.

Authors:  Emmanuelle Mouton-Barbosa; Florence Roux-Dalvai; David Bouyssié; François Berger; Eric Schmidt; Pier Giorgio Righetti; Luc Guerrier; Egisto Boschetti; Odile Burlet-Schiltz; Bernard Monsarrat; Anne Gonzalez de Peredo
Journal:  Mol Cell Proteomics       Date:  2010-01-21       Impact factor: 5.911

Review 2.  Proteomics of human neurodegenerative diseases.

Authors:  Jing Zhang; C Dirk Keene; Catherine Pan; Kathleen S Montine; Thomas J Montine
Journal:  J Neuropathol Exp Neurol       Date:  2008-10       Impact factor: 3.685

3.  Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid.

Authors:  Alberto Lleó; Raúl Núñez-Llaves; Daniel Alcolea; Cristina Chiva; Daniel Balateu-Paños; Martí Colom-Cadena; Gemma Gomez-Giro; Laia Muñoz; Marta Querol-Vilaseca; Jordi Pegueroles; Lorena Rami; Albert Lladó; José L Molinuevo; Mikel Tainta; Jordi Clarimón; Tara Spires-Jones; Rafael Blesa; Juan Fortea; Pablo Martínez-Lage; Raquel Sánchez-Valle; Eduard Sabidó; Àlex Bayés; Olivia Belbin
Journal:  Mol Cell Proteomics       Date:  2019-01-03       Impact factor: 5.911

4.  Establishing the proteome of normal human cerebrospinal fluid.

Authors:  Steven E Schutzer; Tao Liu; Benjamin H Natelson; Thomas E Angel; Athena A Schepmoes; Samuel O Purvine; Kim K Hixson; Mary S Lipton; David G Camp; Patricia K Coyle; Richard D Smith; Jonas Bergquist
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

5.  Spectral counting assessment of protein dynamic range in cerebrospinal fluid following depletion with plasma-designed immunoaffinity columns.

Authors:  Jacques Borg; Alex Campos; Claudio Diema; Núria Omeñaca; Eliandre de Oliveira; Joan Guinovart; Marta Vilaseca
Journal:  Clin Proteomics       Date:  2011-06-03       Impact factor: 3.988

6.  Identification of the soluble form of tyrosine kinase receptor Axl as a potential biomarker for intracranial aneurysm rupture.

Authors:  Jing Xu; Feiqiang Ma; Wei Yan; Sen Qiao; Shengquan Xu; Yi Li; Jianhong Luo; Jianmin Zhang; Jinghua Jin
Journal:  BMC Neurol       Date:  2015-03-05       Impact factor: 2.474

7.  A Multiplex Protein Panel Applied to Cerebrospinal Fluid Reveals Three New Biomarker Candidates in ALS but None in Neuropathic Pain Patients.

Authors:  Anne-Li Lind; Di Wu; Eva Freyhult; Constantin Bodolea; Titti Ekegren; Anders Larsson; Mats G Gustafsson; Lenka Katila; Jonas Bergquist; Torsten Gordh; Ulf Landegren; Masood Kamali-Moghaddam
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

8.  Peptidome analysis of cerebrospinal fluid by LC-MALDI MS.

Authors:  Mikko Hölttä; Henrik Zetterberg; Ekaterina Mirgorodskaya; Niklas Mattsson; Kaj Blennow; Johan Gobom
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

9.  In-depth characterization of the cerebrospinal fluid (CSF) proteome displayed through the CSF proteome resource (CSF-PR).

Authors:  Astrid Guldbrandsen; Heidrun Vethe; Yehia Farag; Eystein Oveland; Hilde Garberg; Magnus Berle; Kjell-Morten Myhr; Jill A Opsahl; Harald Barsnes; Frode S Berven
Journal:  Mol Cell Proteomics       Date:  2014-07-18       Impact factor: 5.911

10.  Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas.

Authors:  Ilijana Begcevic; Davor Brinc; Andrei P Drabovich; Ihor Batruch; Eleftherios P Diamandis
Journal:  Clin Proteomics       Date:  2016-05-15       Impact factor: 3.988
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.